These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 968934)

  • 1. Inhibition of parental tumor colony formation by cells from a semi allogeneic mixed spleen cell reaction.
    Jones TL; Kennedy JC
    Transplantation; 1976 Aug; 22(2):176-83. PubMed ID: 968934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A micro-colony-inhibition method for quantitation of tumor immunity.
    Haskill JS
    J Natl Cancer Inst; 1973 Nov; 51(5):1581-8. PubMed ID: 4762935
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient impaired cell-mediated tumor immunity after acute infection with lymphocytic choriomeningitis virus.
    Güttler F; Bro-Jorgensen K; Jorgensen PN
    Scand J Immunol; 1975; 4(4):327-36. PubMed ID: 1188321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 6. In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity.
    Korn JH; Haskill JS; Holden HT; Radov LA; Ritter FL
    J Natl Cancer Inst; 1978 Jun; 60(6):1391-7. PubMed ID: 306442
    [No Abstract]   [Full Text] [Related]  

  • 7. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
    Huber S; Lucas ZJ
    Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative lung colony assay for tumor immunity in mice.
    Boone CW; Lundberg E; Orme T; Gillette R
    J Natl Cancer Inst; 1973 Nov; 51(5):1731-4. PubMed ID: 4357767
    [No Abstract]   [Full Text] [Related]  

  • 9. Host responses within solid tumors: non-thymus-derived specific cytotoxic cells within a murine mammary adenocarcinoma.
    Haskill JS; Yamamura Y; Radov L
    Int J Cancer; 1975 Nov; 16(5):798-809. PubMed ID: 1081078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.
    Pope BL; Whitney RB; Levy JG; Kilburn DG
    J Immunol; 1976 May; 116(5):1342-6. PubMed ID: 1270799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immune potentiation of drug responses to a murine mammary adenocarcinoma.
    Radov LA; Haskill JS; Korn JH
    Int J Cancer; 1976 Jun; 17(6):773-9. PubMed ID: 947856
    [No Abstract]   [Full Text] [Related]  

  • 12. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
    J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
    Morton DL
    J Natl Cancer Inst; 1969 Feb; 42(2):311-20. PubMed ID: 4303883
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation of fixed antigenic, non-oncogenic and protective neoplastic cells.
    Hakim AA
    Experientia; 1977 Apr; 33(4):518-20. PubMed ID: 862758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro immune interferon induction during tumor evolution.
    Kohan S; Lustig ES; Teyssié AR; Tous M; Ayerra B
    Biomed Pharmacother; 1986; 40(4):150-3. PubMed ID: 3098317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
    Moroson H; Stowe S; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
    [No Abstract]   [Full Text] [Related]  

  • 19. Microfluorometric comparisons of chromatin thermal stability in situ between normal and neoplastic cells.
    Alvarez MR
    Cancer Res; 1973 Apr; 33(4):786-90. PubMed ID: 4696478
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB; Ketcham AS; Hammond WG
    Laryngoscope; 1973 Mar; 83(3):376-87. PubMed ID: 4690029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.